Shots:
- Utepreva has launched the Utepreva Endometrial Sampler, a single-use device designed to improve tissue capture & enable early diagnostic evaluation of endometrial cancer, with availability expected in Oct 2026
- The device combines three mechanisms for single-pass sampling: a sponge tip absorbs tissue & fluid, a plunger-driven suction aspirates cells & prevents loss, & the collected sample supports cytologic, histopathologic, & molecular analyses for comprehensive evaluation
- Preclinical & design verification testing by Medical Murray showed Utepreva captured more simulated endometrial tissue & achieved more uniform disruption vs a comparator, demonstrating statistically significant performance under controlled conditions
Ref: PRnewswire | Image: Utepreva | Press Release
Related News: Pulnovo Raises $100M Led by Medtronic to Advance PADN System for Pulmonary Hypertension
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
